Calcium acetate Completed Phase 3 Trials for Hyperphosphataemia / Renal Failure Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01191255A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis